Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 24Recruiting 13Unknown 12Terminated 9Withdrawn 5Active not recruiting 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Sex Cord-Gonadal Stromal Tumors 1Neoplasms, Germ Cell and Embryonal 1Glioblastoma 1Breast Neoplasms 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Quality of Life × Clear all
NCT03251027 2026-01-27

Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

Thomas Jefferson University

Phase NA Active not recruiting
100 enrolled
CNS

Glioblastoma

NCT00582478 2026-01-07

Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients

Memorial Sloan Kettering Cancer Center

Active not recruiting
650 enrolled
Breast

Breast Neoplasms

NCT03418844 2025-09-22

VIVROVAIRE TR

Centre Francois Baclesse

Phase NA Active not recruiting
268 enrolled

Neoplasms, Germ Cell and Embryonal, Sex Cord-Gonadal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡